BioProcess International is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Michaela Wendeler, Ph.D.
Principal Scientist, Biopharmaceutical Development at AstraZeneca

Profile

Michaela Wendeler is a principal scientist in Biopharmaceutical Development at AstraZeneca. Her team focuses on purification development for novel molecules and on conjugation development for ADCs. Michaela is CMC team lead and oversees the ADC platform team. Prior to joining AstraZeneca in 2009, Michaela worked at the National Institutes of Health/National Cancer Institute. She obtained a PhD in Biochemistry at the University of Bonn, Germany.

Michaela Wendeler, Ph.D.'s Network

Agenda Sessions

  • Meeting Manufacturability Challenges for Antibody-Drug Conjugates

    ,
  • Meeting Manufacturability Challenges for Antibody-Drug Conjugates

    ,